Vor Bio to Participate in the Stifel 2024 Healthcare Conference
2024年11月12日 - 10:00PM
Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering
company, today announced that it will participate in a fireside
chat and host 1x1 investor meetings at the Stifel 2024 Healthcare
Conference.
Stifel 2024 Healthcare Conference Fireside
Chat: Monday, November 18, 2024 at 2:25 pm ETLocation: New York,
NY
A live webcast and archived replay of the fireside chat will be
available on the investors section of www.vorbio.com.
About Vor BioVor Bio is a clinical-stage cell
and genome engineering company that aims to change the standard of
care for patients with blood cancers by engineering hematopoietic
stem cells to enable targeted therapies post-transplant. For more
information, visit: www.vorbio.com.
Contact:
Media & InvestorsSarah Spencer +1
857-242-6076sspencer@vorbio.com
Vor Biopharma (NASDAQ:VOR)
過去 株価チャート
から 11 2024 まで 12 2024
Vor Biopharma (NASDAQ:VOR)
過去 株価チャート
から 12 2023 まで 12 2024
